GB202013558D0 - GRP52 Modularor compounds - Google Patents
GRP52 Modularor compoundsInfo
- Publication number
- GB202013558D0 GB202013558D0 GBGB2013558.8A GB202013558A GB202013558D0 GB 202013558 D0 GB202013558 D0 GB 202013558D0 GB 202013558 A GB202013558 A GB 202013558A GB 202013558 D0 GB202013558 D0 GB 202013558D0
- Authority
- GB
- United Kingdom
- Prior art keywords
- modularor
- grp52
- compounds
- modularor compounds
- grp52 modularor
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/04—Ortho-condensed systems
- C07D491/044—Ortho-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Biomedical Technology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Psychiatry (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Amplifiers (AREA)
- Optical Modulation, Optical Deflection, Nonlinear Optics, Optical Demodulation, Optical Logic Elements (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Priority Applications (12)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB2013558.8A GB202013558D0 (en) | 2020-08-28 | 2020-08-28 | GRP52 Modularor compounds |
| PCT/GB2021/052247 WO2022043714A1 (en) | 2020-08-28 | 2021-08-31 | Gpr52 modulator compounds |
| BR112023003696A BR112023003696A2 (pt) | 2020-08-28 | 2021-08-31 | Compostos moduladores de gpr52 |
| US18/023,411 US20230348416A1 (en) | 2020-08-28 | 2021-08-31 | Gpr52 modulator compounds |
| EP21769501.4A EP4204408A1 (en) | 2020-08-28 | 2021-08-31 | Gpr52 modulator compounds |
| AU2021330379A AU2021330379A1 (en) | 2020-08-28 | 2021-08-31 | GPR52 modulator compounds |
| CN202180073276.0A CN116507622B (zh) | 2020-08-28 | 2021-08-31 | Gpr52调节剂化合物 |
| JP2023514050A JP7761635B6 (ja) | 2020-08-28 | 2021-08-31 | Ｇｐｒ５２モジュレーター化合物 |
| MX2023002389A MX2023002389A (es) | 2020-08-28 | 2021-08-31 | Compuestos moduladores de gpr52. |
| CA3193487A CA3193487A1 (en) | 2020-08-28 | 2021-08-31 | Gpr52 modulator compounds |
| KR1020237010457A KR20230058132A (ko) | 2020-08-28 | 2021-08-31 | Gpr52 조절인자 화합물 |
| IL301007A IL301007B2 (en) | 2020-08-28 | 2023-02-28 | GPR52 modulator compounds |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB2013558.8A GB202013558D0 (en) | 2020-08-28 | 2020-08-28 | GRP52 Modularor compounds |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| GB202013558D0 true GB202013558D0 (en) | 2020-10-14 |
Family
ID=72749711
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| GBGB2013558.8A Ceased GB202013558D0 (en) | 2020-08-28 | 2020-08-28 | GRP52 Modularor compounds |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US20230348416A1 (enExample) |
| EP (1) | EP4204408A1 (enExample) |
| JP (1) | JP7761635B6 (enExample) |
| KR (1) | KR20230058132A (enExample) |
| CN (1) | CN116507622B (enExample) |
| AU (1) | AU2021330379A1 (enExample) |
| BR (1) | BR112023003696A2 (enExample) |
| CA (1) | CA3193487A1 (enExample) |
| GB (1) | GB202013558D0 (enExample) |
| IL (1) | IL301007B2 (enExample) |
| MX (1) | MX2023002389A (enExample) |
| WO (1) | WO2022043714A1 (enExample) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB202003668D0 (en) | 2020-03-13 | 2020-04-29 | Heptares Therapeutics Ltd | GPR52 Modulator compounds |
| EP4139284A1 (en) | 2020-04-22 | 2023-03-01 | Neurocrine Biosciences, Inc. | Gpr52 modulators and methods of use |
| CN122555695A (zh) * | 2023-11-29 | 2026-08-11 | 爱克堤欧生物科学股份有限公司 | 可用作kcnt1抑制剂的杂环化合物 |
| CN121313618B (zh) * | 2025-12-09 | 2026-07-21 | 杭州师范大学附属医院(杭州市第二人民医院) | 丙酸在制备治疗肝豆状核变性肠肝轴紊乱的药物中的应用 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MX373876B (es) * | 2015-04-29 | 2020-03-26 | Arena Pharm Inc | 1-heteroaril-indolin-4-carboxamidas como moduladores de gpr52 útiles para el tratamiento o prevención de trastornos relacionados a las mismas. |
| WO2017077280A1 (en) * | 2015-11-02 | 2017-05-11 | Sonia Lain | Tetrahydroindazoles and medical uses thereof |
| WO2021009003A1 (en) * | 2019-07-16 | 2021-01-21 | Universität Hamburg | Computer-based identification of types in the empirical sciences by tangle theory |
| CN114650992A (zh) * | 2019-11-08 | 2022-06-21 | 赫普泰雅治疗有限公司 | Gpr52调节剂化合物 |
-
2020
- 2020-08-28 GB GBGB2013558.8A patent/GB202013558D0/en not_active Ceased
-
2021
- 2021-08-31 MX MX2023002389A patent/MX2023002389A/es unknown
- 2021-08-31 KR KR1020237010457A patent/KR20230058132A/ko active Pending
- 2021-08-31 WO PCT/GB2021/052247 patent/WO2022043714A1/en not_active Ceased
- 2021-08-31 JP JP2023514050A patent/JP7761635B6/ja active Active
- 2021-08-31 EP EP21769501.4A patent/EP4204408A1/en active Pending
- 2021-08-31 BR BR112023003696A patent/BR112023003696A2/pt unknown
- 2021-08-31 CN CN202180073276.0A patent/CN116507622B/zh active Active
- 2021-08-31 US US18/023,411 patent/US20230348416A1/en active Pending
- 2021-08-31 AU AU2021330379A patent/AU2021330379A1/en active Pending
- 2021-08-31 CA CA3193487A patent/CA3193487A1/en active Pending
-
2023
- 2023-02-28 IL IL301007A patent/IL301007B2/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CN116507622B (zh) | 2026-02-24 |
| IL301007B1 (en) | 2026-04-01 |
| IL301007A (en) | 2023-05-01 |
| WO2022043714A1 (en) | 2022-03-03 |
| US20230348416A1 (en) | 2023-11-02 |
| MX2023002389A (es) | 2023-05-03 |
| BR112023003696A2 (pt) | 2023-04-04 |
| KR20230058132A (ko) | 2023-05-02 |
| EP4204408A1 (en) | 2023-07-05 |
| AU2021330379A1 (en) | 2023-03-30 |
| CN116507622A (zh) | 2023-07-28 |
| CA3193487A1 (en) | 2022-03-03 |
| IL301007B2 (en) | 2026-08-01 |
| JP2023539336A (ja) | 2023-09-13 |
| JP7761635B2 (ja) | 2025-10-28 |
| JP7761635B6 (ja) | 2025-11-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP4452937A4 (en) | CONNECTIONS | |
| GB202001564D0 (en) | Compounds | |
| GB202016614D0 (en) | Compounds | |
| GB202302032D0 (en) | Compounds | |
| GB202103704D0 (en) | Compounds | |
| GB202103008D0 (en) | Compounds | |
| GB202103017D0 (en) | Compounds | |
| GB202020047D0 (en) | Compounds | |
| GB202017406D0 (en) | Compounds | |
| GB202016977D0 (en) | Compounds | |
| GB202014944D0 (en) | Compounds | |
| GB202011811D0 (en) | Compounds | |
| GB202011812D0 (en) | Compounds | |
| FI4441052T3 (fi) | Yhdisteitä | |
| GB202105000D0 (en) | Compounds | |
| GB202103874D0 (en) | Compounds | |
| GB202103482D0 (en) | Compounds | |
| GB202103012D0 (en) | Compounds | |
| GB202102709D0 (en) | Compounds | |
| GB202100645D0 (en) | Compounds | |
| GB202020370D0 (en) | Compounds | |
| GB202019428D0 (en) | Compounds | |
| GB202019427D0 (en) | Compounds | |
| GB202019429D0 (en) | Compounds | |
| GB202018034D0 (en) | Compounds |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| AT | Applications terminated before publication under section 16(1) |